Anthi Anastasia, Machado Roberto F, Jison Maria L, Taveira-Dasilva Angelo M, Rubin Lewis J, Hunter Lori, Hunter Christian J, Coles Wynona, Nichols James, Avila Nilo A, Sachdev Vandana, Chen Clara C, Gladwin Mark T
Vascular Medicine Branch, Clinical Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 2089, USA.
Am J Respir Crit Care Med. 2007 Jun 15;175(12):1272-9. doi: 10.1164/rccm.200610-1498OC. Epub 2007 Mar 22.
Although pulmonary hypertension (PH) is a common complication of sickle cell disease (SCD) associated with high mortality, there exist few data characterizing hemodynamics and cardiopulmonary function in this population.
To characterize hemodynamics and cardiopulmonary function in patients with SCD with and without PH.
Patients with SCD with PH (n = 26) were compared with control subjects with SCD but without PH (n = 17), matched for age, hemoglobin levels, and fetal hemoglobin levels.
Upon catheterization, 54% of the patients with PH had pulmonary arterial hypertension, and 46% had pulmonary venous hypertension. When compared with control subjects, patients with PH exhibited lower six-minute-walk distance (435 +/- 31 vs. 320 +/- 20 m, p = 0.002) and oxygen consumption (50 +/- 3% vs. 41 +/- 2% of predicted, p = 0.02), and also had mild restrictive lung disease and more perfusion abnormalities on radionuclide lung scans. The six-minute-walk distance in this population inversely correlated with tricuspid regurgitant jet velocity (r = -0.55, p < 0.001), and mean pulmonary artery pressure (r = -0.57, p < 0.001), and directly correlated with maximal oxygen consumption (r = 0.49, p = 0.004), even after adjustment for hemoglobin, supporting an independent contribution of increasing pulmonary artery pressures to loss of exercise capacity.
Patients with SCD-associated PH have both pulmonary arterial and venous PH associated with severe limitations in exercise capacity, likely compounded by interstitial lung fibrosis and severe anemia. These data support the use of the six-minute-walk distance as an index of PH and cardiopulmonary function in patients with SCD.
尽管肺动脉高压(PH)是镰状细胞病(SCD)的常见并发症,且与高死亡率相关,但关于该人群血流动力学和心肺功能特征的数据却很少。
描述有和没有PH的SCD患者的血流动力学和心肺功能特征。
将患有PH的SCD患者(n = 26)与年龄、血红蛋白水平和胎儿血红蛋白水平相匹配的无PH的SCD对照受试者(n = 17)进行比较。
导管插入术显示,54%的PH患者患有肺动脉高压,46%患有肺静脉高压。与对照受试者相比,PH患者的六分钟步行距离较短(435±31 vs. 320±20 m,p = 0.002),耗氧量较低(占预测值的50±3% vs. 41±2%,p = 0.02),并且在放射性核素肺扫描中存在轻度限制性肺病和更多的灌注异常。该人群的六分钟步行距离与三尖瓣反流喷射速度呈负相关(r = -0.55,p < 0.001),与平均肺动脉压呈负相关(r = -0.57,p < 0.001),与最大耗氧量呈正相关(r = 0.49,p = 0.004),即使在调整血红蛋白后也是如此,这支持了肺动脉压力升高对运动能力丧失有独立影响。
患有SCD相关PH的患者同时存在肺动脉和肺静脉PH,这与运动能力的严重受限相关,可能因间质性肺纤维化和严重贫血而加重。这些数据支持将六分钟步行距离用作SCD患者PH和心肺功能的指标。